Recalled products — current list 2026
Recalls in Poland are issued by GIS (Chief Sanitary Inspector) for food and cosmetics, GIF (Chief Pharmaceutical Inspector) for medicines, and UOKiK for consumer products. The list below brings every alert together in one place and is updated continuously as new recalls are published.
2 162 alerts in the database • last update:
Latest recalled products
ARTHRYL
The defect consists in the use of incorrect serialization data, resulting in incorrect identification of the medicinal product and failure to meet requirements for verification of authenticity and identification of the pack. Potential effects: possible use of an inappropriate or falsified drug, lack of treatment efficacy, treatment complications.
VALZEK
This risk may be caused by the presence of N-nitrosodimethylamine (NDMA) contamination in the active substance contained in the medicinal product, which may affect human health and life. Potential effects: possible carcinogenic effects and other serious health disorders with long-term exposure.
VALZEK
Presence of N-nitrosodimethylamine (NDMA) contamination above the acceptable limit was found in the active substance Valsartan, which may pose a threat to patients' health and life. Potential effects: poisoning, carcinogenic effects, health complications with long-term use.
REMUREL
It was found that the tested sample of the medicinal product does not meet the manufacturer's specification regarding the parameter: contamination with particles invisible to the naked eye. Potential effects: complications after injection, inflammatory reactions, lack of treatment safety.
OZURDEX
A silicone particle of about 300 µm in diameter was detected in some batches of the medicinal product Ozurdex, which constitutes a potential quality defect and may pose a risk to patients' health. Potential effects: complications after administration, tissue irritation, visual disturbances, serious ophthalmic complications.
LECALPIN
It was found that in the outer cartons intended for the medicinal product Lecalpin 20 mg there were primary packages (blisters) of the medicinal product Lecalpin 10 mg, batch No. 268018. Potential effects: lack of treatment efficacy or improper dosing.
MILVANE
Lack of information on contraindications for the use of the medicinal product Milvane in combination with certain medicines used in antiviral therapy. Potential effects: lack of efficacy, adverse reactions, treatment complications.
KALIUM EFFERVRSCENS BEZCUKROWY
Repeated complaints were reported regarding incorrectly printed expiry dates and it was found that the products lacked a unique identifier and tamper-evident safety feature on the packaging, as well as batch certification and release by the Qualified Person. Potential effects: lack of treatment efficacy, use after expiry, falsification risk, treatment complications.
SPASMOLINA
Incorrect expiry date was printed on outer packaging and required safety features (unique identifier and anti-tampering device) were missing, combined with lack of batch certification and release by the Qualified Person. Potential effects: lack of treatment efficacy, use of the product after expiry date, risk of falsification or tampering, treatment complications.
ANDEPIN
Lack of a unique identifier and tamper‑evident feature, together with incorrect expiry date labelling, may prevent proper medicine identification and facilitate circulation of unauthorised or expired packs. Potential effects: lack of treatment efficacy or complications related to use of expired or falsified medicine.
SPASMOLINA
Failure to include a unique identifier and tamper-evident feature on the packaging and placing the batch on the market without recertification and release by the Qualified Person may result in distribution of a product with unverified quality and authenticity. Potential effects: lack of efficacy or complications due to use of a product with unconfirmed quality.
ENEMA
Identified risk of a decrease in the content of the preservative – methyl parahydroxybenzoate, meaning the product may not meet established quality requirements and may not ensure adequate microbiological stability. Potential effects: lack of efficacy, infections, complications in patients.
NuTRiflex Lipid special
It was found that the glucose solution may not meet specification requirements at the end of shelf-life, indicating a quality defect of the medicinal product and a potential threat to patients’ health or life. Potential effects: lack of treatment efficacy, metabolic disturbances, complications after infusion.
XALOPTIC FREE
Exceeding specification limits for related substances content in several batches of Xaloptic Free and suspected occurrence of the same quality defect in further batches, indicating non‑compliance with quality requirements. Potential effects: lack of treatment efficacy, adverse reactions, therapy complications.
XALOPTIC FREE
It was found that the specification limit for related substances was exceeded in batches of the medicinal product Xaloptic Free, with a likelihood of this non‑compliance occurring in further batches. Potential effects: possible lack of efficacy or unforeseen adverse reactions.
ROTARIX
Irregularities in the manufacturing process were detected, leading to possible insufficient filling of the last 50 oral applicators of the Rotarix batch, meaning failure to meet quality requirements for the volume parameter. Potential effects: lack of vaccination efficacy.
BENZACNE
A quality defect of the product was found regarding the gel appearance and active substance content, resulting from a defect of the immediate packaging, which may lead to improper quality and performance of the product. Potential effects: lack of treatment efficacy or unpredictable drug action.
BENODIL
A quality defect was identified consisting of out-of-specification results for the parameter of budesonide-related substances content, which may indicate an improper impurity profile and lack of compliance with quality requirements. Potential effects: possible reduced treatment efficacy or increased risk of adverse reactions.
BENODIL
Out-of-specification results were found in archival samples tested by the manufacturer, regarding the parameter of budesonide-related substances content, which means failure to meet established quality requirements. Potential effects: possible lack of treatment efficacy or unforeseen adverse reactions.
PRESARTAN H
Detected nitrosamine-group impurities (NDMA and NDEA) in the active substance losartan potassium, which may affect human health and life, even though the levels do not exceed acceptable limits. Potential effects: possible carcinogenic effects and health complications with long-term use.
PRESARTAN H
The risk may be caused by the presence of nitrosamine-group contaminants in the active substance contained in these medicinal products, which may affect human health and life. Potential effects: possible carcinogenic effects, chronic health risk, potential complications with long-term use.
PRESARTAN
This risk may be caused by the presence of nitrosamine-group impurities in the active substance contained in the above-mentioned medicinal products, which may affect human health and life. Potential effects: possible carcinogenic effects and health complications during long-term use.
PRESARTAN
Impurities of N-nitrosodimethylamine (NDMA) and N-nitrosodiethylamine (NDEA) were detected in the active substance Losartanum kalicum from the manufacturer Zhejiang Huahai Pharmaceutical Co. Ltd. Potential effects: possible carcinogenic effects and health risks with long-term use.
KORZEŃ ARCYDZIĘGLA
Failure to meet quality requirements of the medicinal product was found due to the presence of disqualifying features, which makes a potential risk to patients’ health or life plausible. Potential effects: lack of efficacy, possible adverse effects or health complications.
GLICEROL
Out-of-specification results were found for aldehydes, sugars, impurity A and related substances during stability testing of batch 01916, which makes a potential threat to the quality and safety of the medicinal product plausible. Potential effects: lack of efficacy or unforeseen adverse reactions.
BUDIXON NEB
Test results out of specification in archival samples concerning the content of budesonide related substances. Potential effects: reduced efficacy, increased risk of adverse reactions.
BUDIXON NEB
Out-of-specification results for the content of budesonide-related substances. Potential effects: reduced efficacy or increased risk of adverse reactions.
BENODIL
Test results out of specification: elevated related substances content of budesonide. Potential effects: reduced efficacy, increased risk of adverse reactions.
BENODIL
Out-of-specification results for related substances of budesonide. Potential effects: reduced efficacy or altered safety of use.
BDS N
Out-of-specification results for the content of related substances of budesonide. Potential effects: reduced efficacy or safety of the medicinal product.
APO-LOZART
Detected contamination with N-nitroso-N-methylamino butyric acid (NMBA) in some batches of the losartan potassium active substance. Potential effects: carcinogenicity, increased long-term health risk.
APO-LOZART
Detected contamination of the active substance with N-nitroso-N-methylamino-butyric acid (NMBA), an N-nitrosamine that may affect human health and life. Potential effects: increased cancer risk, systemic toxic effects.
LOREBLOK HCT
Detection of contamination: N-nitroso-N-methylamino-butyric acid (NMBA) in the active substance losartan. Potential effects: long-term carcinogenic risk.
LOREBLOK
Contamination with N-nitroso-N-methylamino butyric acid (NMBA) was detected in some batches of the losartan active substance (from Hetero Labs Limited). Potential effects: increased risk of carcinogenic effects with long-term exposure.
IRPRESTAN
Detection of N-nitrosodiethylamine (NDEA) above the acceptable limit in the active substance sourced from Zhejiang Huahai. Potential effects: carcinogenic action and long-term health risk.
Cabletech carbon monoxide detector model URZ0409
The detector poses a hazard due to incorrect operation of alarm thresholds, resulting in exceeding the permissible exposure time to carbon monoxide. Potencjalne skutki: exposure to carbon monoxide, carbon monoxide poisoning, threat to health and life.
Cabletech carbon monoxide detector model URZ0407
The detector poses a hazard due to irregular operation of alarm thresholds, resulting in exceeding the permissible exposure time of the user to carbon monoxide and potentially delaying the warning about the presence of CO. Potential effects: carbon monoxide poisoning, life-threatening condition.
PECFENT
Suspected defect in the primary packaging of the PecFent batch, potentially causing loss of seal/integrity. Potential effects: incorrect dose (evaporation of solution), risk to health and life.
XALOPTIC FREE
Does not meet specification: elevated impurity content — 15(5)-latanoprost, single unknown impurities and increased sum of unknown and total impurities. Potential effects: risk of adverse reactions or reduced efficacy.
FLUCINAR N
Out-of-specification result in a reference sample — impurities originating from fluocinolone acetonide. Potential effects: reduced efficacy, skin adverse effects (irritation, allergic reactions).
Ella Sonoma Oak White crib with drawer
The product is unsafe due to non-rounded edges of the boards, drawer and its cover, springs with sharp edges, and wooden pegs located too close to the child’s access zone. Potential effects: cuts, mechanical injuries, complications requiring medical intervention.
Straight tubular slide 6 m long
The product poses a risk due to the lack of protective barriers preventing climbing on the outer surface of the tubular structure and the lack of required impact area and sufficient fall space. Potencjalne skutki: injuries from falls, bruises, more serious bodily harm.
DINO 16" bicycle
The product poses a risk due to design defects (insufficient handlebar turning radius). Potencjalne skutki: fall of a child while riding, injuries.
DINO 14" bicycle
The product poses a hazard due to design defects (insufficient handlebar turning radius and too small spacing of the stabiliser wheels), which may lead to loss of balance and a child falling while riding. Potential effects: injuries, bruises, more serious harm due to falling.
FOREST sofa
The sofa may pose a risk to users due to the lack of stability of the unsupported part of the sleeping surface, protruding beyond the bedding container and, when loaded, causing uncontrolled lifting of the inner edge of the backrest. Potential effects: user fall, bodily injuries.
2-in-1 sun visor "WIZ CLEAR HD CAR VISOR"
The visor has a rigid material, lacks the ability to absorb or dissipate energy and has no safety warnings, which creates a risk of head injuries to the driver in dynamic contact, e.g. during sudden braking or a road collision. Potential effects: head and other bodily injuries.
C’est La Vie Design children's trousers, Style No: 2074
Improperly used waist drawstrings, freely moving in the channel with unsecured, fraying ends, may catch on objects and cause accidents. Potential effects: bodily injuries (cuts, bruises, fractures, head injuries).
Children's trousers C'est La Vie Fashion Collection No: 50150
Due to the improper use of drawstrings, users of the trousers may suffer bodily injuries such as cuts, bruises, fractures and head injuries. Potencjalne skutki: bodily injuries, including cuts, bruises, fractures and head injuries.
Children's sweatpants C’est La Vie Fashion, Style No: 4604
Due to the improper use of drawstrings, users of the trousers may suffer bodily injuries such as cuts, bruises, fractures and head injuries. Potential effects: bodily injury, including cuts, bruises, fractures, head injuries.
Children's sweatpants C'est La Vie Fashion, Style No: 4607
Due to improper use of drawstrings in the waist, users of the trousers may suffer bodily injuries, including cuts, bruises, fractures and head injuries. Potencjalne skutki: bodily injuries (cuts, bruises, fractures, head injuries).
Children’s trousers C’est La Vie Design, Style No: 2073
Due to the improper use of drawstrings, users of the trousers may suffer bodily injuries such as cuts, bruises, fractures and head injuries. Potential effects: bodily injury, head trauma.
CLEO sofa
The sofa does not maintain the required stability when unfolded (sleeping function), creating a risk of the user falling and suffering limb fracture. Potential effects: injuries, including bone fractures.
Weekend grill SUP 720N
Organoleptic tests by the Trade Inspection showed that the grill may pose a hazard to users due to the insufficient depth of the firebox, increasing the risk of burns during use. Potential effects: burns.
La Grandeur glass oil lamp
The product poses a hazard due to design defects resulting in lack of stability, which may cause the lamp to tip over, leading to a child drinking the lamp oil or sucking the wick soaked with lamp fuel, which may result in lung injuries. Potential effects: lung injury, respiratory complications.
Carbon monoxide detector model NCC-1
The detector does not trigger an alarm at carbon monoxide concentrations of 55 ppm, 100 ppm and 300 ppm, preventing users from being warned about dangerous gas levels and potentially leading to carbon monoxide poisoning. Potencjalne skutki: carbon monoxide poisoning, risk to health and life.
Children's hooded jacket MHM
The MHM jacket poses a hazard due to the hood drawstring with free ends, which can catch and tighten around the child’s neck, causing strangulation or a fall. Potential effects: strangulation, fall-related injuries.
Children’s sweatshirt KIDS SHOCOLET model 323
The sweatshirt has drawstrings with free, overly long ends at the hood and waist area, plus a rear drawstring that may snag or wrap around protruding parts of equipment or moving objects. Potential effects: strangulation, cuts.
Children's sweatshirt KIDS SHOCOLET model 349
The sweatshirt has a drawstring inserted in the hood tunnel, creating a risk of it getting caught or wrapped around protruding parts of equipment or moving objects, causing strangulation and injuries. Potential effects: strangulation, injuries
Decorative kerosene lamp Decorative & Functional
The product poses a risk due to improper design of the fuel inlet closure and opening, allowing children to access the fuel, and the lack of the required warning “keep the oil lamp out of the reach of children”. Potential effects: burns, poisoning.
MARIAN bed
Organoleptic tests showed that due to the lack of a safety rail on one side of the upper bed and the excessive distance from the floor to the first ladder step, the bed’s construction is unsafe for users, creating a risk of falling and limb fracture. Potencjalne skutki: injuries, including limb fractures.
Browse recalls by topic
Frequently asked questions
What are GIS alerts?
GIS (Chief Sanitary Inspector) alerts are official warnings about food products that have been recalled from the Polish market due to health hazards like salmonella, listeria, E. coli or foreign objects.
What are GIF alerts?
GIF (Chief Pharmaceutical Inspector) alerts are warnings about pharmaceutical products and medicines that have been recalled due to quality or safety issues.
What are UOKiK alerts?
UOKiK (Office of Competition and Consumer Protection) alerts are warnings about dangerous consumer products in Poland, including toys, electronics and household items that pose safety risks.
What to do if you bought a recalled product?
Stop using or consuming the product immediately. Most recalled products can be returned to the store for a full refund, even without a receipt. On each alert page you will find a direct link to the official GIS/GIF report with detailed information from the authorities.
What to do if you have this product?
A recall means the product may be unsafe. Here is what to do if you have it at home.
-
1
Do not eat or use the product
Stop using or consuming it immediately and keep it out of reach of children.
-
2
Check the batch number and expiry date
Compare the batch/lot number and the best-before or expiry date with the details in the alert — sometimes only specific batches are affected.
-
3
Return it to the shop
You can take the product back to the shop where you bought it. For a safety recall a refund is due even without a receipt.
-
4
Get help and report it
If you feel unwell after using the product, contact a doctor. You can also report the case to the relevant authority — GIS, GIF or UOKiK.
General guidance for recalled products in Poland. Always follow the specific instructions in the official alert and from the manufacturer or retailer.